top of page

Welcome to Apexell, the global leader in IPRs of human disease

Introducing our law firm
dna-g13ebc9e5d_1920_edited.jpg

Apexell, starting with the development of new anti-cancer drugs using our patent rights and entry into the global market. Also using our pharmaceutical technology, we focus on securing additional patent rights, as well as entering into various fields such as attracting healing centers, operating hospitals, and establishing donation centers.

Introducing Apexell Co., Ltd

Apexell focuses on :

A. Anticancer drug development research

B. Overseas clinical trials

C. Out of License

D. Expansion of patent rights

E. Pharmacy Data Research

F. Hospital Facility Operations

G. Establishment of Healing Center

H. Establishment of Donor Organizations

I. Attracting investors

We are striving to become a global professional company in the field of bio and pharmaceuticals. Furthermore, we intend to contribute to the development of society by holding practical patent rights as well as supporting technology research and development and operating a donation foundation through active activities in related industries.

Business Sectors

01.

New drug develoment

Based on the substance patents we have, we are concentrating on the development of new drugs including anti-cancer drugs, and at the same time, supplementing the patent rights.

02.

Clinical Trial

We are planning clinical trials in overseas Southeast Asian countries, and MOUs with local global companies that we can use have been completed, and local government officials are also included in our infrastructure.

03.

License Out

We have a wealth of experience in contacting and discussing with global pharmaceutical companies for license out in the past, and we focus on maximizing our profits by executing local license out at an appropriate clinical trial stage according to our business schedule.

04.

IPRs

The most important and valuable item for Apexell is the potential of patent rights. We intend to focus on commercialization and monetization through the process of holding patent rights for fields such as bio and pharmaceuticals for which basic research has been completed at each university and research institute.

05.

Hospital operation

Apexell is planning consignment operation for western and oriental medicine hospitals based on its technology. In particular, we aim to attract and treat patients and generate profits by actively utilizing our anticancer drugs that have undergone clinical trials.

06.

Healing Center

Apexell plans to operate a high-end healing center with the motif of a general nursing home. We recruit domestic and foreign patients as members and provide the highest quality facilities and disease management and treatment services by professional medical staff.

07.

R&D

Along with research and development on anticancer drugs, Apexell plans additional R&D processes in the bio and pharmaceutical fields through the establishment and operation of its own research center, and focuses on holding various patents and growing into a global company.

08.

Donation Foundation

Apexell plans to return to society the profits generated through various business operations. We plan to actively provide financial support to the vulnerable in Korea suffering from diseases and start-up companies that lack financial power despite having good ideas and technology.

Our Partners

Apexell has government agencies, domestic university hospitals, global pharmaceutical companies, financial companies, and accounting firms as partner infrastructure. Apexell is collaborating with such professional human resources to smoothly carry out the business in each area it plans.

안산단원병원.png
로고1.png
KakaoTalk_20220817_131227438.png

News

마힌드라.jpg

SEPTEMBER, 2021

 Apexell corporation was established, and detailed discussions about clinical trials are in progress with Mahindra Group in India for the anticancer drug   business. And in contact with a global pharmaceutical company for the final purpose of licensing out.

analysis-gb2ff2d109_1920.jpg

JULY, 2021

Based on the fact that the substance crosses the brain's BBB, Apexell's research team embarked on basic research into the treatment of brain-related diseases. 

News & Updates of
 

실험

Contact us

V421, 6, Teheran-ro 79-gil, Gangnam-gu, Seoul, Republic Korea

Suit 515, 3345 Wilshire Blvd, LosAngeles, California 90505, USA

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for submitting!

Global leader in IPRs of Human Disease

  • White LinkedIn Icon
  • White Facebook Icon

V421, 6, Teheran-ro 79-gil, Gangnam-gu, Seoul, Republic Korea

Suit 515, 3345 Wilshire Blvd, LosAngeles, California 90505, USA

bottom of page